PT100301A - Acidos piridazinonoaceticos - Google Patents

Acidos piridazinonoaceticos Download PDF

Info

Publication number
PT100301A
PT100301A PT100301A PT10030192A PT100301A PT 100301 A PT100301 A PT 100301A PT 100301 A PT100301 A PT 100301A PT 10030192 A PT10030192 A PT 10030192A PT 100301 A PT100301 A PT 100301A
Authority
PT
Portugal
Prior art keywords
methyl
acid
oxo
dihydro
pyridazinoacetic
Prior art date
Application number
PT100301A
Other languages
English (en)
Portuguese (pt)
Inventor
Banavara Lakshmana Mylari
William J Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT100301A publication Critical patent/PT100301A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT100301A 1991-03-28 1992-03-26 Acidos piridazinonoaceticos PT100301A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67691991A 1991-03-28 1991-03-28

Publications (1)

Publication Number Publication Date
PT100301A true PT100301A (pt) 1993-06-30

Family

ID=24716565

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100301A PT100301A (pt) 1991-03-28 1992-03-26 Acidos piridazinonoaceticos

Country Status (19)

Country Link
EP (1) EP0582643A1 (enExample)
JP (1) JPH06500793A (enExample)
CN (1) CN1065269A (enExample)
AU (1) AU658887B2 (enExample)
BR (1) BR9205810A (enExample)
CA (1) CA2107104A1 (enExample)
CZ (1) CZ387092A3 (enExample)
DE (1) DE9290035U1 (enExample)
FI (1) FI934222A0 (enExample)
HU (1) HUT67836A (enExample)
IE (1) IE920979A1 (enExample)
IL (1) IL101325A0 (enExample)
MX (1) MX9201414A (enExample)
NZ (1) NZ242152A (enExample)
PT (1) PT100301A (enExample)
TW (1) TW207998B (enExample)
WO (1) WO1992017446A2 (enExample)
YU (1) YU30392A (enExample)
ZA (1) ZA922238B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240657T3 (es) 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
ATE352551T1 (de) 2001-03-30 2007-02-15 Pfizer Prod Inc Pyridazinon aldose reductase inhibitoren
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
CN111617072B (zh) * 2019-02-27 2023-06-20 苏州凯祥生物科技有限公司 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase

Also Published As

Publication number Publication date
IE920979A1 (en) 1992-10-07
BR9205810A (pt) 1994-06-28
TW207998B (enExample) 1993-06-21
WO1992017446A3 (en) 1992-11-26
MX9201414A (es) 1992-10-01
YU30392A (sh) 1994-11-15
CN1065269A (zh) 1992-10-14
FI934222L (fi) 1993-09-27
CZ387092A3 (en) 1994-02-16
NZ242152A (en) 1994-07-26
CA2107104A1 (en) 1992-09-29
FI934222A7 (fi) 1993-09-27
WO1992017446A2 (en) 1992-10-15
ZA922238B (en) 1993-09-27
AU658887B2 (en) 1995-05-04
EP0582643A1 (en) 1994-02-16
AU1779692A (en) 1992-11-02
DE9290035U1 (de) 1993-11-18
IL101325A0 (en) 1992-11-15
FI934222A0 (fi) 1993-09-27
HU9302728D0 (en) 1993-12-28
HUT67836A (en) 1995-05-29
JPH06500793A (ja) 1994-01-27

Similar Documents

Publication Publication Date Title
EP0673366B1 (en) 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
PT89346B (pt) Processo para a preparacao de novas lactamas triciclicas contendo grupos sulfridilo e de composicoes farmaceuticas que as contem
US5268386A (en) Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia
EP0436307B1 (en) Substituted oxophthalazinyl acetic acids and analogs thereof
PT100301A (pt) Acidos piridazinonoaceticos
US20040220415A1 (en) Benzofuran derivatives
EP0041410A1 (fr) Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
EP0266102B1 (en) Quinoxalinone derivatives
EP0533827B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent
IE45696B1 (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
JP2002538117A (ja) 肥満の予防または治療のための医薬の製造のための多環2−アミノチアゾール系の使用
HU219361B (en) Aryl-alkyl-thiadiazinones, pharmaceutical compositions containing them and process for preparing them
KR860001581B1 (ko) 스피로-3-헤테로-아졸론의 제조방법
US4806551A (en) N-dihydroindolylethyl-sulphonamides
HU215953B (hu) Eljárás indolszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
HU193274B (en) Process for preparing phenthiazines
US5508280A (en) 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
KR860001507B1 (ko) 5-(치환된 페닐) 히단토인의 제조방법
EP0581767A1 (en) 5H-DIBENZO (a, d) CYCLOHEPTENES USED AS MUSCARINIC RECEPTOR ANTAGONISTS.
DE19711617A1 (de) Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JPH10158234A (ja) 2−フェニルアズレン誘導体及びその製造方法
EP0188150A1 (fr) Procédé de préparation d'isomères optiques de thiazolo [3,2-a] pyrimidines, les nouveaux isomères ainsi obtenus, les compositions pharmaceutiques qui les contiennent et les intermédiaires pour mettre en oeuvre ce procédé
CA1044697A (fr) Procede de preparation de nouveaux azabicycloalcanes disubstitues
FR2468613A2 (fr) Nouveaux derives de la thienopyridine, leur preparation et les medicaments qui les contiennent
JPH0745475B2 (ja) 複素多環式化合物

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930219

FC3A Refusal

Effective date: 19990329